Table 1: Tumor characteristics from available studies
Authors |
Year |
Country |
Sample Size |
% among all BC |
Mean age |
Laterality |
Mean tumor size |
T stage |
Lymph nodes involve-ment |
Metasta-sis |
Grade |
HR |
Treatment |
5-years OS |
|||||||||||||||||
|
|
|
|
|
|
LT |
RT |
BL |
|
1 |
2 |
3 |
4 |
X |
+ |
0 |
1 |
0 |
I |
II |
III |
ER % |
PR % |
HER2 % |
S |
L |
R |
C |
H |
T |
% |
El-Ghazayerli
|
1963 |
Egypt |
14 |
6.4 |
41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temmim et al
|
2001 |
Kuweit |
41 |
2 |
55 |
24 |
13 |
0 |
-- |
5 |
23 |
5 |
8 |
0 |
11 |
24 |
-- |
-- |
1 |
21 |
16 |
88.8 |
61 |
-- |
-- |
-- |
-- |
-- |
-- |
- |
67 |
Hali et al
|
2002 |
Morocco |
12 |
-- |
60 |
7 |
5 |
0 |
-- |
|
|
4 |
8 |
0 |
|
8 |
7 |
|
|
|
|
|
|
|
8 |
|
5 |
3 |
|
|
|
Omari-Alaoui et al
|
2002 |
Morocco |
71 |
0.94 |
60 |
-- |
-- |
-- |
-- |
|
|
9 |
37 |
0 |
|
31 |
13 |
|
|
58 |
|
|
|
|
59 |
1 |
44 |
17 |
53 |
|
|
Beyrouti et al
|
2003 |
Tunisie |
23 |
-- |
68 |
-- |
-- |
-- |
-- |
1 |
6 |
2 |
14 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sellal et al
|
2011 |
Morocco |
21 |
-- |
|
-- |
-- |
-- |
-- |
1 |
12 |
1 |
7 |
0 |
7 |
8 |
|
0 |
4 |
13 |
3 |
81 |
81 |
|
14 |
1 |
17 |
7 |
8 |
|
|
Gilbert et al |
2011 |
Egypt |
211 |
-- |
57.5 |
83 |
66 |
3 |
3.8 |
-- |
-- |
-- |
-- |
-- |
76 |
46 |
|
|
1 |
94 |
21 |
81 |
71 |
|
43 |
|
5 |
5 |
|
|
|
Gilbert et al |
2011 |
Moroccco |
132 |
-- |
63.9 |
56 |
64 |
7 |
3.6 |
|
|
|
|
|
76 |
47 |
|
|
9 |
68 |
7 |
85.4 |
78 |
|
72 |
|
20 |
20 |
|
|
|
Hali et al
|
2011 |
Morocco |
20 |
-- |
61.3 |
11 |
9 |
|
7.5 |
|
|
|
|
|
9 |
11 |
7 |
|
|
5 |
|
100 |
100 |
|
14 |
|
|
|
|
|
|
Bourhafour et al
|
2011 |
Morocco |
127 |
-- |
62*
|
|
|
|
|
6 |
18 |
22 |
79 |
0 |
16 |
102 |
37 |
|
|
|
|
64 |
64 |
|
104 |
1 |
60 |
28 |
57 |
|
63 |
Tawil et al
|
2012 |
Lebanon |
47 |
-- |
62*
|
|
|
|
2.2*
|
|
|
|
|
|
12 |
14 |
|
|
2 |
18 |
13 |
94 |
64.7 |
9.4 |
|
|
|
|
|
|
|
Beshbeshi et al
|
2012 |
Egypt |
37 |
0.8 |
57.7*
|
24 |
13 |
|
|
1 |
6 |
13 |
17 |
0 |
15 |
18 |
3 |
|
1 |
26 |
10 |
|
|
|
32 |
2 |
33 |
34 |
21 |
|
60.5 |
Laabadi et al
|
2013 |
Morocco |
6 |
-- |
65.3 |
|
|
|
4.42 |
|
|
1 |
4 |
1 |
1 |
4 |
1 |
|
2 |
3 |
1 |
100 |
83.3 |
|
5 |
|
4 |
4 |
4 |
|
|
Soliman et al
|
2014 |
Egypt |
69 |
-- |
58 |
|
|
|
2.9 |
19 |
48 |
2 |
|
0 |
|
56 |
5 |
|
14 |
37 |
17 |
|
|
|
69 |
|
63 |
65 |
|
|
46.4 |
Gilbert et al
|
2014 |
Egypt |
44 |
-- |
59.4 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
13 |
-- |
-- |
-- |
15 |
4 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Elbachiri et al
|
2017 |
Morocco |
40 |
-- |
-- |
-- |
-- |
-- |
-- |
4 |
5 |
13 |
16 |
2 |
7 |
30 |
15 |
-- |
3 |
25 |
12 |
-- |
-- |
17.5 |
31 |
|
27 |
40 |
26 |
4 |
62 |
*Median not mean; LT=left; RT=right; BL= Bilateral; S=surgery; L=Lumpectomy; R= Radiation therapy; C= Chemotherapy; H= Hormonal therapy; T=Trastuzuma